Autism Market Pipeline Review and Analysis
Report 2017
“The Latest Pharmaceutical and Healthcare disease
pipeline guide Autism - Pipeline Review, H1 2017,
provides an overview of the Autism (Central
Nervous System) pipeline landscape.”
Summary
The Latest Pharmaceutical and Healthcare disease pipeline guide Autism - Pipeline Review, H1
2017, provides an overview of the Autism (Central Nervous System) pipeline landscape.
Complete Report Available @ http://www.radiantinsights.com/research/autism-pipeline-
review-h1-2017
Autism, also known as complex developmental disability, is a neurodevelopment disorder
characterized by social interaction, verbal and nonverbal communication and repetitive behaviors.
Risk factors include child's sex, family history, fragile X syndrome, Tourette syndrome and epilepsy.
Treatment includes SSRIs (selective serotonin reuptake inhibitors), antidepressants, antipsychotics,
and sedatives.
Report Highlights
The Pharmaceutical and Healthcare latest pipeline guide Autism - Pipeline Review, H1 2017,
provides comprehensive information on the therapeutics under development for Autism (Central
Nervous System), complete with analysis by stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive
Follow Us: